menu
    • menu

    Company profile for Alpha Tau Medical

    NEW Drugs in Dev: 2
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alpha Tau Medical was founded in 2016 and focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, preclinical and clinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were p...
    Alpha Tau Medical was founded in 2016 and focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, preclinical and clinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 16 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alpha Tau MedicalIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    20 Dr. George Wise St., Tel Aviv 6997712
    Telephone
    Telephone
    +1 833-455-3278
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alphatau.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alphataumedical
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alpha Tau: 100% Local Control, 67% Response in Glioblastoma Trial
    Alpha Tau: 100% Local Control, 67% Response in Glioblastoma Trial

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3291734/0/en/alpha-tau-announces-groundbreaking-interim-results-from-its-u-s-alpha-dart-recurrent-glioblastoma-trial-with-100-local-disease-control-67-complete-response-rate-and-favorable-safet.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Alpha Tau Fills Pivotal Skin Cancer Trial, Eyes FDA DaRT Approval
    Alpha Tau Fills Pivotal Skin Cancer Trial, Eyes FDA DaRT Approval

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291075/0/en/alpha-tau-completes-patient-enrollment-in-its-u-s-pivotal-skin-cancer-study-advancing-towards-goal-of-fda-approval-of-alpha-dart-to-treat-recurrent-cutaneous-squamous-cell-carcinom.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Alpha Tau to Host Call on First GBM Patient Interim Results
    Alpha Tau to Host Call on First GBM Patient Interim Results

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291131/0/en/alpha-tau-to-host-conference-call-to-discuss-interim-results-from-first-three-patients-treated-for-recurrent-glioblastoma.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Alpha Tau Treats First Pancreatic Cancer Patient in Italy
    Alpha Tau Treats First Pancreatic Cancer Patient in Italy

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3290096/0/en/alpha-tau-successfully-treats-first-pancreatic-cancer-patient-in-italy-with-alpha-dart-at-the-university-of-verona-s-pancreas-institute.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Alpha Tau's DaRT Shows 100% Local Control in Pancreatic Cancer
    Alpha Tau's DaRT Shows 100% Local Control in Pancreatic Cancer

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286810/0/en/alpha-tau-announces-100-local-disease-control-rate-and-favorable-safety-profile-observed-in-alpha-dart-pancreatic-cancer-trials-presented-at-ddw-2026.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Alpha Tau Showcase 3 Alpha DaRT Pancreatic Cancer Studies at ASCO
    Alpha Tau Showcase 3 Alpha DaRT Pancreatic Cancer Studies at ASCO

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281701/0/en/alpha-tau-announces-presentation-of-pancreatic-cancer-data-at-upcoming-asco-annual-meeting-showcasing-combined-results-from-three-alpha-dart-pancreatic-cancer-studies.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search